29th May 2025

A 50-year-old patient with type 2 diabetes mellitus and inadequate glycaemic control on metformin alone is being considered for the addition of a second-line oral antidiabetic medication.

A 50-year-old patient with type 2 diabetes mellitus and inadequate glycaemic control on metformin alone is being considered for the addition of a second-line oral antidiabetic medication. You opt for a medication that stimulates insulin secretion by modulating potassium channels on beta-cells. What medication have you prescribed?

Select the SINGLE most appropriate option from the list below. Select ONE option only.